In this video Allison Monette, RD, ND discusses how medical nutrition therapy help patients with diabetes and why it is important for all clinicians to integrate nutrition and lifestyle medicine into their practices.

In this video presentation Annalouise O’Connor, PhD provides an in-depth overview of homocysteine, its function in the human body and why it is clinically important, as well as the risk factors for raised homocysteine. Dr O’Connor describes the link between homocysteine and methylation, and the pathways involved in homocysteine metabolism for the function of SAM and SAH. During the presentation, she covers specific nutritional supplementation for the management of raised homocysteine.

What tools exist to help prevent chronic inflammation and disease? In his talk “Start the Resolution: Stopping the Progression of Chronic Disease,” Robert Martindale, MD, PhD, Professor and Chief for the Division of GI and General Surgery at Oregon Health & Science University, explores the newest paradigm in metabolic mediation: inflammation resolution physiology. Dr. Martindale differentiates between anti-inflammatory and pro-resolution actions in the body. He delves into the unique roles that polyunsaturated fatty acids and a novel lipid mediator class,…

Osama Hamdy, MD, PhD is the Medical Director of the Obesity Clinical Program at the Joslin Diabetes Center in Boston and Professor of Medicine at Harvard Medical School. Dr. Hamdy  works in the inpatient clinic at Joslin and is the creator of the Joslin’s "Why Wait program." This presentation entitled “The Reality of Carbohydrate Intolerance” by Dr. Hamdy focuses on the clinical management of obese and diabetic patients. The video reviews the day to day practices that cause the epidemic…

In the first part of an interview series, Charles Serhan, PhD, DSc answers the question “How and when did you determine the significant of resolution physiology to human health?” Dr. Serhan shares an edifying history of resolution physiology: from early microscope observations of leukocytic infiltration, to the turning point lipoxin discoveries in the 1990s, to the latest research insights and inquiries today. Once thought to be a passive event mediated by chemokines, resolution is now known to be an active…

In the 2nd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Can you describe some therapeutic areas where specialized pro-resolving mediators are currently being investigated for clinical use?” Dr. Serhan discusses the most current therapeutic research assessing SPM efficacy, including pulmonary, cardiometabolic, vascular, joint and cognitive health, as well as pain and wound healing. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital…

In the 3rd part of a new SPM interview series, Charles Serhan, PhD, DSc answers the question: “Are there any recent findings or results in resolvins research that have surprised you?” Dr. Serhan discusses the recently discovered resolution role of specialized pro-resolving mediators (SPMs) in the adaptive immune response, including the regulation of B cell function and facilitating antibody production. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury at Brigham and Women’s Hospital…

In the 4th part of the SPM interview series with Charles Serhan, PhD, DSc, he answers the question: “Besides peripheral blood, can pro-resolving mediators be measured in other tissues? If so, which ones?” Dr. Serhan shares current research findings on SPM measurement in the human body, demonstrating several human tissues and fluids where SPMs have been found. These discoveries will directly inform analytical methods for SPM measurement moving forward. Dr. Serhan also discusses the “coagulation clock”, as well as gender-…

In the 5th part of the SPM interview series with Charles Serhan, PhD, DSc, he explores the latest research to answer the question: “What is the role of resolvins in cancer?” Listen in as Dr. Serhan shares the impact resolvins have  on tumor debris clearance, tumor burden and cytotoxic agent use in animal models, as well as the potential for applications in human oncologic treatment. Charles Serhan, PhD, DSc is Director of the Center for Experimental Therapeutics and Reperfusion Injury…

In the 6th part of the SPM interview series, Charles Serhan, PhD, DSc provides insights into the query: “What role do you envision lipid mediators and active resolution will play in future clinical decision-making?” Dr. Serhan shares an edifying history on resolvins, from molecular work following their discovery in 2000, to the growing body of in vivo animal model results in inflammatory and infection processes, and now to the ongoing human clinical studies. Charles Serhan, PhD, DSc is Director of the…